AAV Upstream Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 5 days ago

AAV Upstream Intern

positionCambridge, Massachusetts, United States of America
timeInternship
remoteOnsite
seniorityIntern
money$37/hr - $41/hr
workcardStart in 2026 Summer

Alexion Pharmaceuticals, Inc. is seeking Junior and Master's Level students for a 10-week internship role at their Cambridge, MA site. The role involves designing and executing studies to support process development, participating in lab organization, and completing relevant documentation.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & BenefitsbadNo H1Bnote

Responsibilities

Design and execute studies to support the ongoing process development for selected program(s)
Participate in lab organization/workflow improvement initiatives
Complete relevant documentation (production records, data analysis etc)

Qualification

Cell cultureAseptic techniqueTransfectionData analysis toolsPublic speakingPresentation designCollaboration

Required

Junior and Master's Level students studying Biomedical Engineering, Biotechnology, or a related field
Candidates must have an expected graduation date after August 2026
Cell culture and aseptic technique required
US Work Authorization is required at time of application
Ability to report onsite to Cambridge, MA 5 days per week. This role will not provide relocation assistance

Preferred

Transfection, Data analysis tools (GraphPad, JMP, Excel) preferred
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design

Benefits

Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage

Company

Alexion Pharmaceuticals, Inc.

twittertwittertwitter
Glassdoor3.9
company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
dateFounded in 1992
location
Boston, Massachusetts, USA
people-size1001-5000 employees
web-link
https://alexion.com

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin

Recent News

bloomberglaw.com
AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case
2025-12-20
Business Wire
Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline and Competitive Intelligence Report 2025 - ResearchAndMarkets.com
2025-12-01
EuropaWire
AstraZeneca Secures FDA Approval for Koselugo to Treat Adults with NF1 Plexiform Neurofibromas Following Positive Phase III KOMET Results
2025-11-20
Company data provided by crunchbase